TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
BioNema AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,519
|
2,174
|
1,701 |
| Financial expenses |
1
|
1
|
3 |
| Earnings before taxes |
746
|
211
|
219 |
| EBITDA |
785
|
253
|
283 |
| Total assets |
2,050
|
1,640
|
1,520 |
| Current assets |
848
|
1,349
|
1,208 |
| Current liabilities |
203
|
206
|
130 |
| Equity capital |
1,846
|
1,434
|
1,391 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.0%
|
87.4%
|
91.5% |
| Turnover per employee |
1,260
|
1,087
|
850 |
| Profit as a percentage of turnover |
29.6%
|
9.7%
|
12.9% |
| Return on assets (ROA) |
36.4%
|
12.9%
|
14.6% |
| Current ratio |
417.7%
|
654.9%
|
929.2% |
| Return on equity (ROE) |
40.4%
|
14.7%
|
15.7% |
| Change turnover |
417
|
465
|
-625 |
| Change turnover % |
20%
|
27%
|
-27% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.